Hayden E. Klein

October 23, 2021

The WISDOM study—Women Informed to Screen Depending On Measures of risk—was launched to test a personalized approach to screening compared to annual mammograms. Funmi Olopade, MD, FACP, is a professor of Medicine and Human Genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, and a co-investigator of WISDOM. She discussed how the COVID-19 pandemic actually helped increase participation in the WISDOM study and what it means for future trials.

October 22, 2021

Researchers hope these findings help develop methods to assess cognitive function in patients with rheumatoid arthritis.

October 20, 2021

While sales have gone up, the research does not directly show whether there is an increase in people smoking cigarettes.

October 20, 2021

The WISDOM study—Women Informed to Screen Depending On Measures of risk—was launched to test a personalized approach to screening compared to annual mammograms. Funmi Olopade, MD, FACP, is a professor of Medicine and Human Genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, and a co-investigator of WISDOM. She is an expert on understanding the etiology and genomic basis of cancer progression in diverse populations and has published extensively on both genetic and non-genetic risk factors for breast cancer. She discussed overcoming early challenges of low enrollment of Black women in the study.

October 18, 2021

The low-dose tablet will help pediatric patients weighing between 14 kg and 25 kg who are virologically suppressed or new to antiretroviral therapy.

October 15, 2021

Some alcohol, but not more than 1 drink per day, was linked to a 55% lower risk of type 2 diabetes in women with a history of gestational diabetes.

October 13, 2021

The task force determined that potential harms of adults aged 60 and older using aspirin for prevention outweighed the benefits.

October 12, 2021

The study found that a combination of the Chinese symptom-based questionnaire and microspirometry could provide the most efficient and cost-effective way of identifying patients who need treatment for COPD.

October 07, 2021

Research presented during IDWeek 2021 showed data on V114, Merck’s investigational 15-valent pneumococcal conjugate vaccine.

October 04, 2021

Patients with T2D had elevated blood glucose levels but there were no notable differences in levels between surviving and non-surviving patients with T2D.